ViroCell Biologics is a contract development and manufacturing organisation (CDMO) specialising in the design and GMP production of viral vectors, including lentiviral and gamma-retroviral vectors. Their mission is to accelerate novel cell and gene therapies, enabling them to enter clinical trials and ultimately improve patient outcomes.

ViroCell has over 20 years of expertise in vector manufacturing and is committed to delivering high-quality, GMP-compliant viral vectors. Their streamlined processes and fast-track solutions ensure the efficient and de-risked development of vectors for clinical use, significantly shortening time-to-market.

Key Products and Services

• Lentiviral vector production
• Gamma-retroviral vector production
• GMP manufacturing for clinical trials
• Vector design and optimisation
• Process development and scale-up
• Custom vector services

ViroCell’s dedication to innovation and its robust manufacturing capabilities ensure it remains a trusted partner for advancing cell and gene therapies into clinical trials.